Nestle Health Science exports FSMPs made in Taizhou to Europe

The Isosource series of products by Nestle. [Photo/Taizhou Daily]

Nestle Health Science (China), located in Taizhou's China Medical City, recently completed the packaging of its Isosource series of foods for special medical purposes (FSMPs), which are bound for European countries like Germany and Italy.

The first batch, totaling 900 metric tons, has an estimated sales revenue exceeding 100 million yuan (around $14 million).

Isosource is a line designed for individuals who, while having largely intact digestive and absorption abilities, are malnourished or at risk of malnutrition.

In April of this year, a sudden interruption in the supply of core ingredients for the product posed a potential challenge. Upon learning about this issue, the Taizhou Medical High-Tech Zone worked quickly to address it by collaborating with the provincial FSMP inspection center. They screened over 20 domestic suppliers and selected three whose processes and standards were consistent with those of the original supplier.

"This not only resolved our raw material supply issue but also helped break down standard barriers," said Hu Guili, director of the testing laboratory at Nestle Health Science (China). The production capacity for this product is expected to reach 4,000 tons by 2026, with sales projected to exceed 600 million yuan.

Taizhou Medical High-Tech Zone provides comprehensive support to Nestle Health Science (China). [Photo/Taizhou Daily]

Since 2013, when Nestle established its first Asia-Pacific liquid FSMP base in China Medical City, the Taizhou Medical High-Tech Zone's market supervision bureau has formed a service team to provide comprehensive support throughout the plant's establishment, registration, and approval.

This excellent service ecosystem continues to attract further investments from Nestle. In March, Nestle launched a new health food project in Taizhou, focusing on probiotics and hydrolyzed protein powders.

"We have positioned the Taizhou factory as a global innovation hub, with plans to launch multiple new product lines over the next three years. These will focus on probiotics, protein powder-based health foods, and FSMPs for conditions such as diabetes and kidney disease," said Zhao Yang, head of product registration.